PortfoliosLab logoPortfoliosLab logo
HRMY vs. AIQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HRMY vs. AIQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and Global X Artificial Intelligence & Technology ETF (AIQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HRMY achieves a -14.22% return, which is significantly lower than AIQ's 35.98% return.


HRMY

1D
3.85%
1M
-1.50%
YTD
-14.22%
6M
-13.24%
1Y
-9.09%
3Y*
-3.02%
5Y*
-0.67%
10Y*

AIQ

1D
-1.40%
1M
21.10%
YTD
35.98%
6M
36.15%
1Y
69.19%
3Y*
37.50%
5Y*
19.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HRMY vs. AIQ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
HRMY
Harmony Biosciences Holdings, Inc.
-14.22%8.75%6.53%-41.38%29.22%17.95%-2.32%
AIQ
Global X Artificial Intelligence & Technology ETF
35.98%31.89%24.11%55.39%-36.44%17.09%20.44%

Correlation

The correlation between HRMY and AIQ is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Aug 20, 2020

0.26

The correlation between HRMY and AIQ shifts across timeframes, from 0.19 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HRMY vs. AIQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY
HRMY Risk / Return Rank: 3131
Overall Rank
HRMY Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
HRMY Sortino Ratio Rank: 2929
Sortino Ratio Rank
HRMY Omega Ratio Rank: 2929
Omega Ratio Rank
HRMY Calmar Ratio Rank: 3131
Calmar Ratio Rank
HRMY Martin Ratio Rank: 3232
Martin Ratio Rank

AIQ
AIQ Risk / Return Rank: 8181
Overall Rank
AIQ Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
AIQ Sortino Ratio Rank: 8181
Sortino Ratio Rank
AIQ Omega Ratio Rank: 8080
Omega Ratio Rank
AIQ Calmar Ratio Rank: 8080
Calmar Ratio Rank
AIQ Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRMY vs. AIQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Global X Artificial Intelligence & Technology ETF (AIQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HRMYAIQDifference

Sharpe ratio

Return per unit of total volatility

-0.22

3.02

-3.24

Sortino ratio

Return per unit of downside risk

-0.02

3.70

-3.73

Omega ratio

Gain probability vs. loss probability

1.00

1.49

-0.49

Calmar ratio

Return relative to maximum drawdown

-0.26

4.22

-4.49

Martin ratio

Return relative to average drawdown

-0.49

14.59

-15.08

HRMY vs. AIQ - Sharpe Ratio Comparison

The current HRMY Sharpe Ratio is -0.22, which is lower than the AIQ Sharpe Ratio of 3.02. The chart below compares the historical Sharpe Ratios of HRMY and AIQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HRMYAIQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.22

3.02

-3.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

0.76

-0.77

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

0.84

-0.89

Drawdowns

HRMY vs. AIQ - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, which is greater than AIQ's maximum drawdown of -44.66%. Use the drawdown chart below to compare losses from any high point for HRMY and AIQ.


Loading charts...

Drawdown Indicators


HRMYAIQDifference

Max Drawdown

Largest peak-to-trough decline

-68.48%

-44.66%

-23.82%

Max Drawdown (1Y)

Largest decline over 1 year

-34.49%

-16.47%

-18.02%

Max Drawdown (3Y)

Largest decline over 3 years

-50.81%

-26.35%

-24.46%

Max Drawdown (5Y)

Largest decline over 5 years

-68.48%

-44.66%

-23.82%

Current Drawdown

Current decline from peak

-47.30%

-1.40%

-45.90%

Average Drawdown

Average peak-to-trough decline

-35.20%

-9.80%

-25.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.69%

4.76%

+13.93%

Volatility

HRMY vs. AIQ - Volatility Comparison

Harmony Biosciences Holdings, Inc. (HRMY) has a higher volatility of 10.05% compared to Global X Artificial Intelligence & Technology ETF (AIQ) at 8.60%. This indicates that HRMY's price experiences larger fluctuations and is considered to be riskier than AIQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HRMYAIQDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.05%

8.60%

+1.45%

Volatility (6M)

Calculated over the trailing 6-month period

30.17%

18.46%

+11.71%

Volatility (1Y)

Calculated over the trailing 1-year period

41.40%

23.04%

+18.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.04%

25.33%

+24.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.40%

25.50%

+26.90%

Dividends

HRMY vs. AIQ - Dividend Comparison

HRMY has not paid dividends to shareholders, while AIQ's dividend yield for the trailing twelve months is around 0.14%.


PositionTTM20252024202320222021202020192018
AIQ
Global X Artificial Intelligence & Technology ETF
0.14%0.18%0.14%0.16%0.56%0.15%0.50%0.51%0.51%
HRMY
Harmony Biosciences Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


HRMY and AIQ have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HRMY has higher volatility (10.05%) compared to AIQ (8.60%). In terms of maximum drawdown, HRMY dropped -68.48% vs AIQ's -44.66%.

AIQ currently has the higher Sharpe Ratio (3.02 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HRMY and AIQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer